Events2Join

Surrogate endpoint


Surrogate Endpoint Resources for Drug and Biologic Development

Usually clinical trials are needed to show that the surrogate endpoint can be relied upon to predict, or correlate with, clinical benefit in a ...

Definition of surrogate endpoint - NCI Dictionary of Cancer Terms

surrogate endpoint ... In clinical trials, an indicator or sign used in place of another to tell if a treatment works. Surrogate endpoints include a shrinking ...

Surrogate endpoint - Wikipedia

A surrogate endpoint (or surrogate marker) is a measure of effect of a specific treatment that may correlate with a real clinical endpoint

Table of Surrogate Endpoints That Were the Basis of Drug Approval ...

# Surrogate endpoint is part of a composite of biomarker surrogate endpoints. * Mechanism agnostic refers to cases where there are many ...

Surrogate endpoint - Toolkit

Surrogate endpoint ... A surrogate endpoint is a laboratory measure or a physical sign that is intended to be used as a substitute for an endpoint measuring a ...

Surrogate Endpoint | Definitive Healthcare

What is a surrogate endpoint? A surrogate endpoint can be a laboratory measurement, radiographic image, physical sign, or other measures that is not itself a ...

Reasonably Likely Surrogate Endpoint - NCBI

An endpoint supported by strong mechanistic and/or epidemiologic rationale such that an effect on the surrogate endpoint is expected to be ...

A framework for the definition and interpretation of the use of ...

Surrogate endpoints are used in trials as a substitute of the treatment effects of an intervention on the target outcome(s) of ultimate interest, events ...

Surrogate endpoints: a key concept in clinical epidemiology

Abstract. Surrogate endpoints are biomarkers or intermediate outcomes that are used as substitutes for clinical outcomes of interest, ...

Word of the Month: Biomarkers and surrogate endpoints - PhRMA

This week, we are taking a look at the critical role biomarkers and surrogate endpoints play in enhancing the drug development process.

Frequently asked questions on surrogate endpoints in oncology ...

In this article, we provide a comprehensive review of surrogate endpoints currently used in oncology trials both in curative and advanced disease settings.

Surrogate endpoints: a key concept in clinical epidemiology

Surrogate endpoints are biomarkers or intermediate outcomes that are used as substitutes for clinical outcomes of interest, often to expedite ...

Surrogate Endpoints.pdf - EUnetHTA

However, for the initial (first) assessment, surrogate endpoints might be accepted if the validity of the surrogate/final clinical endpoint relationship has.

Surrogate endpoints in trials: a call for better reporting

Using a surrogate endpoint as a substitute for a patient-relevant final outcome enables randomised controlled trials (RCTs) to be conducted ...

Surrogate Endpoints in Clinical Trials | Annual Reviews

Surrogate markers are often used in clinical trials settings when obtaining a final outcome to evaluate the effectiveness of a treatment ...

Time to Review the Role of Surrogate End Points in Health Policy

We provide a summary of the present use of surrogate end points in health care policy, discussing the case for and against their adoption and reviewing ...

FDA Acceptance of Surrogate End Points for Cancer Drug Approval

We identified 194 unique drug authorizations for 132 drugs that were based on surrogate end points from 1992 through 2019.

Use of Surrogate Endpoints in Oncology - YouTube

Presentation Title: Use of Surrogate Endpoints in Oncology Session 3: Clinical Validation and Regulatory Acceptance of Biomarkers as ...

5.3 - Surrogate Endpoints | STAT 509

5.3 - Surrogate Endpoints. A surrogate endpoint is one that is measured in place of the biologically definitive or clinically meaningful endpoint. A surrogate ...

Surrogate endpoint - EUPATI Toolbox

A surrogate endpoint (or marker) is a measure which in itself is not the outcome that the study treatment aims to elicit. For example, blood pressure ...